George Kassianos

1.4k total citations
42 papers, 747 citations indexed

About

George Kassianos is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, George Kassianos has authored 42 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 17 papers in Health and 7 papers in Infectious Diseases. Recurrent topics in George Kassianos's work include Influenza Virus Research Studies (17 papers), Vaccine Coverage and Hesitancy (17 papers) and Respiratory viral infections research (11 papers). George Kassianos is often cited by papers focused on Influenza Virus Research Studies (17 papers), Vaccine Coverage and Hesitancy (17 papers) and Respiratory viral infections research (11 papers). George Kassianos collaborates with scholars based in United Kingdom, Germany and Spain. George Kassianos's co-authors include Thomas Weinke, Robert W. Johnson, Didier Bouhassira, Alain Leplège, Kenneth E. Schmader, Endre Ludwig, H. Lode, Raúl Ortíz de Lejarazu, Ernest Kuchar and Aneta Nitsch‐Osuch and has published in prestigious journals such as Vaccine, BMC Medicine and BMJ Open.

In The Last Decade

George Kassianos

37 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Kassianos United Kingdom 16 532 188 117 108 93 42 747
Jan Smetana Czechia 10 446 0.8× 119 0.6× 144 1.2× 20 0.2× 23 0.2× 25 697
Paige Lewis United States 21 674 1.3× 406 2.2× 332 2.8× 15 0.1× 43 0.5× 48 1.2k
Kimp Walton United States 11 356 0.7× 217 1.2× 123 1.1× 5 0.0× 248 2.7× 15 735
John Iskander United States 17 372 0.7× 275 1.5× 333 2.8× 16 0.1× 14 0.2× 24 944
Silvia Pérez-Vilar United States 15 341 0.6× 117 0.6× 175 1.5× 11 0.1× 11 0.1× 39 586
Mónica López‐Lacort Spain 13 324 0.6× 29 0.2× 111 0.9× 58 0.5× 22 0.2× 30 463
Sapna P. Sadarangani Singapore 14 205 0.4× 51 0.3× 144 1.2× 30 0.3× 26 0.3× 32 542
Antonio Muscatello Italy 16 145 0.3× 23 0.1× 520 4.4× 40 0.4× 26 0.3× 60 1.0k
Robert T. Chen United States 7 559 1.1× 381 2.0× 235 2.0× 9 0.1× 107 1.2× 8 884
Dapeng Yin China 7 187 0.4× 40 0.2× 88 0.8× 30 0.3× 5 0.1× 19 296

Countries citing papers authored by George Kassianos

Since Specialization
Citations

This map shows the geographic impact of George Kassianos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Kassianos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Kassianos more than expected).

Fields of papers citing papers by George Kassianos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Kassianos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Kassianos. The network helps show where George Kassianos may publish in the future.

Co-authorship network of co-authors of George Kassianos

This figure shows the co-authorship network connecting the top 25 collaborators of George Kassianos. A scholar is included among the top collaborators of George Kassianos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Kassianos. George Kassianos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Μellou, Kassiani, et al.. (2024). Evolution and Impact of Hepatitis A Epidemiology in Europe—Systematic Literature Review of the Last 20 Years. Journal of Viral Hepatitis. 32(1). e14030–e14030.
3.
Reynard, Charles, James Campling, Adam Gordon, et al.. (2024). Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment. Expert Review of Vaccines. 23(1). 1052–1067. 1 indexed citations
4.
Kassianos, George, et al.. (2024). Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines. Vaccines. 12(1). 57–57.
5.
Kassianos, George, et al.. (2023). Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review. Infectious Diseases and Therapy. 12(9). 2193–2219. 3 indexed citations
6.
Lusignan, Simon de, Filipa Ferreira, Manasa Tripathy, et al.. (2023). Impact of General Practitioner Education on Acceptance of an Adjuvanted Seasonal Influenza Vaccine among Older Adults in England. Behavioral Sciences. 13(2). 130–130. 4 indexed citations
7.
Bunge, Eveline M., George Kassianos, Kassiani Μellou, et al.. (2023). Hepatitis A occurrence and outbreaks in Europe over the past two decades: A systematic review. Journal of Viral Hepatitis. 30(6). 497–511. 14 indexed citations
8.
Puig‐Barberà, Joan, George Kassianos, Philippe Vanhems, et al.. (2021). A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom. Influenza and Other Respiratory Viruses. 16(3). 417–428. 11 indexed citations
9.
Kassianos, George, Ashis Banerjee, Alan Hampson, et al.. (2020). Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countries. Drugs in Context. 9. 1–13. 17 indexed citations
11.
Moore, Catherine, Raúl Ortíz de Lejarazu, Simon de Lusignan, et al.. (2020). The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus. Vaccine. 38(38). 6047–6056. 32 indexed citations
12.
Esposito, Susanna, Elisabetta Franco, G. Gavazzi, et al.. (2018). The public health value of vaccination for seniors in Europe. Vaccine. 36(19). 2523–2528. 32 indexed citations
13.
Kassianos, George, et al.. (2016). British HIV Association (BHIVA) guidelines on the use of vaccines in HIV-positive people. 26. 1–1. 15 indexed citations
14.
Kassianos, George, Patricia R. Blank, Oana Falup‐Pecurariu, et al.. (2016). Influenza vaccination: key facts for general practitioners in Europe—a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands. Drugs in Context. 5. 1–18. 19 indexed citations
15.
Kassianos, George, et al.. (2014). The non-anticoagulation costs of atrial fibrillation management: findings from an observational study in NHS Primary Care. Drugs in Context. 3. 1–11. 4 indexed citations
16.
Kassianos, George, et al.. (2013). Current management of atrial fibrillation: an observational study in NHS primary care. BMJ Open. 3(11). e003004–e003004. 7 indexed citations
17.
Lode, H., Endre Ludwig, & George Kassianos. (2013). Pneumococcal Infection — Low Awareness as a Potential Barrier to Vaccination: Results of a European Survey. Advances in Therapy. 30(4). 387–405. 29 indexed citations
18.
Kassianos, George. (2010). Vaccination for tomorrow: the need to improve immunisation rates.. PubMed. 20(1). 13–6. 6 indexed citations
19.
Johnson, Robert W., Didier Bouhassira, George Kassianos, et al.. (2010). The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Medicine. 8(1). 37–37. 296 indexed citations
20.
Kassianos, George, et al.. (1998). Immunization:Childhood and travel Health. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026